Physician profile
Amy Wolfe
NPI 1386295665
$1,079.04
in general payments reported to CMS, 2019-2025
12 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.93 · 2022: $242 · 2023: $224 · 2024: $300 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.67 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.20 | 2021-2024 | |
| Astellas Pharma US INC | $380.82 | 2023-2025 | Veozah |
| Organon LLC | $49.37 | 2024 | |
| Exeltis, USA INC. | $43.49 | 2023-2024 | Slynd |
| Otsuka America Pharmaceutical, INC. | $37.47 | 2025 | Rexulti |
| Coopersurgical, INC. | $23.76 | 2025 | Paragard T 380a |
| Boston Scientific Corporation | $23.43 | 2025 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $20.56 | 2022 | |
| Amgen INC. | $18.29 | 2021 | |
| Hologic Sales and Service, LLC | $15.55 | 2025 | Aptima |
| Supernus Pharmaceuticals, INC. | $14.17 | 2025 | Qelbree |
| Baxter Healthcare | $12.93 | 2023 | Tisseel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.